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Glutamate excitotoxicity plays a major role in the loss of retinal gangl ion cells (RGCs) in 
g laucoma. The toxic effects of g lu tamate on RGCs are med ia ted by the over stimulation of N-
methyl-d-aspartate (NMDA) receptors. Accordingly, NMDA receptor antagonists have been 
suggested to inhibit excitotoxicity in RGCs a n d delay the progression a n d visual loss in g laucoma 
patients. The purpose of the present study was to examine the potential of neuroprotective effect 
of M g acetyl taurate (MgAT) on RGC dea th induced by NMDA. MgAT was proposed mainly due 
to combinat ion of magnesium (Mg) a n d taurine which may provide neuroprotect ion by dual 
mechanisms of act ion, i.e. inhibition of NMDA receptors a n d antioxidant effects. 
In our study, the morphometric measurement on H&E staining was observed with reduct ion in 
number of gangl ion cells in NMDA group compared to the MgAT pre- a n d co- t reated groups. 
Similar results were observed in Caspase-3 staining. The results further corroborated by the 
estimation of markers of oxidative stress, caspase-3 activity in retina. 
For the first t ime, w e showed that pre-treatment with intravitreal MgAT prevents RGC apoptosis 
induced by NMDA. Overall, our d a t a demonstrated that the pretreatment with MgAT was more 
effective that co - a n d post-treatment. This protect ive effect of MgAT against NMDA-induced 
retinal cell apoptosis cou ld b e attr ibuted to reduct ion of retinal oxidative stress a n d act ivat ion of 
neuroprotective mechanisms. 
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5.2 Enhanced Executive Summary 
Background: Glutamate excitotoxicity plays a major role in the loss of retinal ganglion 
cells (RGCs) in glaucoma. The toxic effects of glutamate on RGCs are mediated by the 
overstimulation of N-methyl-D-aspartate (NMDA) receptors. Accordingly, NMDA receptor 
antagonists have been suggested to inhibit excitotoxicity in RGCs and delay the 
progression and visual loss in glaucoma patients. The purpose of the present study was 
to examine the potential neuroprotective effect of Mg acetyltaurate (MgAT) on RGC 
death induced by NMDA. MgAT was proposed mainly due to the combination of 
magnesium (Mg) and taurine which may provide neuroprotection by dual mechanisms of 
action, i.e., inhibition of NMDA receptors and antioxidant effects. 
Methods: Rats were divided into 5 groups and were given intravitreal injections. Group 1 
(PBS group) was injected with vehicle; group 2 (NMDA group) was injected with NMDA 
while groups 3 (pre-), 4 (co-), and 5 (post-) treatments were injected with MgAT, 24 h 
before, in combination or 24 h after NMDA injection respectively. NMDA and MgAT were 
injected in PBS at doses 160 and 320 nmol, respectively. Seven days after intravitreal 
injection, the histological changes in the retina were evaluated using hematoxylin & 
eosin (H&E) staining. Optic nerves were dissected and stained in Toluidine blue for 
grading on morphological neurodegenerative changes. The extent of apoptosis in retinal 
tissue was assessed by caspase-3 immunofluorescence staining. The estimation of 
oxidative stress in retina was done using enzymelinked immunosorbent assay (ELISA) 
technique 
Results: The retinal morphometry showed reduced thickness of ganglion cell layer 
(GCL) and reduction in the number of retinal cells in GCL in NMDA group compared to 
the MgAT-treated groups. Caspase-3 staining showed increased number of apoptotic 
cells in inner retina. The results were further corroborated by the estimation of oxidative 
stress in retina. 
Conclusion: In conclusion, current study revealed that intravitreal MgAT prevents retinal 
and optic nerve damage induced by NMDA. Overall, our data demonstrated that the 
pretreatment with MgAT was more effective than co- and posttreatment. This protective 
effect of MgAT against NMDA-induced retinal cell apoptosis could be attributed to the 
reduction of retinal oxidative stress. 
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5.3 Introduction 
Glaucoma is characterized by damage to the optic nerve, which leads to progressive and 
irreversible vision loss (Casson et al. 2012). It is the second most common cause of 
blindness worldwide after cataract. It is estimated that 4.5 million people are suffering 
from glaucoma-related blindness and this number is expected to rise to 11.2 million by 
2020 (Quigley and Broman 2006). Most therapies for glaucoma are directed at the 
reduction of the intraocular pressure (IOP). Conventional wisdom holds that excessive 
pressure within the eye leads to retinal ganglion cell (RGC) loss and optic nerve damage 
seen in this disease. However, the elevated IOP is only one of the risk factors that lead 
to RGC apoptosis. Several other risk factors also contribute to RGC loss in glaucoma. 
Studies have shown that many of these risk factors culminate into glutamate-mediated 
toxicity to RGCs and glutamate selectively damages RGCs in the mammalian eye 
(Dreyer and Lipton 1999). Glutamate is the principal excitatory neurotransmitter in the 
central nervous system (CNS). However, excessive activation of glutamate-gated 
membrane channels may lead to irreversible injury to neurons. Glutamatergic 
excitotoxicity, results primarily from intracellular accumulation of calcium ions and in 
retina it was first described by Lucas and Newhouse (1957). Because of the relatively 
high permeability of N-methyl-D-aspartate (NMDA)-type glutamate- gated channels to 
calcium ions, neurons are particularly sensitive to injury associated with excessive 
activity of this channel subtype (Choi 1988). RGCs are known to express NMDA-type 
channels, and glutamatergic excitotoxicity, mediated by NMDA channels, has been 
demonstrated to contribute significantly to RGC injury in both the in vitro and animal 
models (Levy and Lipton 1990; Sucher et al. 1991; Kitano et al. 1996; Pang et al. 1999; 
Luo et al. 2001). From a therapeutic standpoint, NMDA receptors are potential targets of 
intervention to prevent RGC death (Lipton 1993; Chidlow et al. 2007; Russo et al. 2008). 
Glutamate, however, mediates synaptic transmission essential for normal function of the 
nervous system. Hence, complete blockade of NMDA receptor activity causes 
unacceptable side effects (Seki and Lipton 2008). From this point of view, magnesium 
(Mg) as physiological antagonist of NMDA receptors might be good therapeutic 
instrument in the treatment of NMDA-mediated ocular pathological conditions (Agarwal et 
al., 2014). Mg ions block NMDA receptor-mediated component of synaptic transmission 
and systemically administered Mg antagonizes the neurotoxic effects of NMDA in in vivo 
and in vitro experiments. For example, systemic treatment with Mg can prevent the death 
of motoneurons that are rendered susceptible to the excitotoxic effects of NMDA by 
nerve injury (Gougoulias et al. 2004). In an autoradiographic study, Mg sulfate treatment 
decreased NMDA receptor binding in the rat brain (Hallak et al. 1994). Previous studies 
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